A Ajith, M Merimi, MK Arki… - Frontiers in …, 2024 - frontiersin.org
CD4+ CD25+ FOXP3+ T regulatory cells (Tregs) are a subset of the immunomodulatory cell population that can inhibit both innate and adaptive immunity by various regulatory …
Regulatory T‐cell (Treg) therapy is under clinical investigation for the treatment of transplant rejection, autoimmune disease, and graft‐versus‐host disease. With the advent of genome …
DA Boardman, S Mangat, JK Gillies, VCW Fung… - bioRxiv, 2024 - biorxiv.org
The potency of regulatory T cell (Treg) therapy has been transformed through use of chimeric antigen receptors (CAR). However, to date, CAR Treg therapy has not achieved …
Regulatory T cells (Tregs) are a promising cell therapy for the prevention of immune- mediated pathologies including autoimmune diseases, allergy, transplant rejection and graft …
Regulatory T cell (Treg) therapy is under clinical investigation for the treatment of transplant rejection, autoimmune disease, and graft-versus-host disease. With the advent of genome …
Regulatory T cells (T reg s) are a specialized subset of CD4+ T cells defined by expression of the transcription factor Foxp3. These cells have key roles in preventing the development …